FDA panel backs Glaxo cervical cancer vaccine (Reuters)

Sexual Health - Y! Health Sexual Health & STDs News - 2009, September 9, 7:58 PM

Reuters - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday.

Read more | Previous | Next